Artificial Intelligence

Clearsense unveils its AI strategy at HIMSS 2026, aiming to cut costs and transform passive data archives into active intelligence hubs for healthcare.

Clio rebrands its ShareDo acquisition to Clio Operate, a strategic move to challenge incumbents and capture the lucrative large law firm technology market.

Hong Kong's OP Investment Management reports record 2025 growth, riding historic rallies in China and Korea to solidify its role as a key platform.

Following years of M&A, Perigon Wealth Management is building a proprietary AI-powered platform to drive organic growth and empower its advisors.

FinVolution Group is set to release its 2025 financials, with investors watching to see if international growth and AI tech can navigate market headwinds.

Patriot Memory's industrial arm, ACPI, unveils extreme-performance PCIe Gen5 SSDs and DDR5 RAM, targeting the demanding AI, edge, and 5G markets.

With new federal funding and key milestones met, E3 Lithium's DLE technology is set to unlock vast lithium resources from Alberta's oil brines.

With a historic $2B Series C and a $14.6B valuation, Nscale is escalating the global race to build the power grid for the AI revolution.

A landmark partnership creates a fully regulated, end-to-end path for tokenizing assets, signaling a major shift for institutional finance in Europe.

Fintech firm Affiniti secures a key financing deal with Column to expand its AI-powered financial platform for America's underserved small businesses.

Nordic Semiconductor's new entry-level Bluetooth LE SoCs promise to slash costs, fueling a new wave of affordable smart sensors, tags, and wearables.

Beijing is pouring trillions into AI, 6G, and biomanufacturing to dominate the next tech era, offering Europe partnership amidst rising competition.

Early access programs for a rare blindness therapy in France, Israel, and the US offer hope to patients and provide a crucial financial lifeline for the company.

An undisclosed Eastern European nation is deploying covert, AI-driven radar from UK's Blighter to counter rising geopolitical and hybrid threats.

A new trial in China tests a dual-action antibody for esophageal cancer, a top killer. The therapy aims to unleash a two-pronged immune attack on tumors.

Global investment giant H.I.G. Capital adopts ToltIQ's AI platform, signaling a major shift in how private equity firms evaluate deals and manage risk.

An in-depth look at the Nooro foot massager reveals a gap between its marketing claims, FDA clearance, and a pattern of customer service complaints.

Brookfield Real Assets Income Fund announces a key manager departure, signaling a deeper integration with its vast institutional resources for investors.

Dfns' new Payouts API moves beyond single-provider systems, offering competitive, auditable stablecoin-to-fiat conversions for institutions.

As AI reshapes medicine, one veterinary firm's 'No AI' policy is earning major awards and the loyalty of the vets it serves. Here's why.